product Name:ethyl N-[3-amino-4-(methylamino)benzoyl]-N-pyridin-2-yl-beta-alaninate
- Dabigatran intermediates; 3-[(3-Amino-4-Methylamino-Benzoyl)-Pyridin-2-Yl-Amino]-Propionic Acid Ethyl Ester; Dabigatran etexilate intermediates; Alanine,N-[3-amino-4-(methylamino)benzoyl]-N-2-pyridinyl-,ethyl ester; Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate; 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester; b-Alanine, N-[3-amino-4-(methylamino)benzoyl]-N-2-pyridinyl-, ethyl ester; 3-[3-amino-4-(methylaminobenzoyl)-pyridin-2-ylamni]propionic acid ethyl ester; N-[3-amino-4-(methylamino)benzoyl]-N-2-pyridinyl-beta-Alanine ethyl ester; 3-[(3-Amino-4-methyl aminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester; Ethyl-3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate; 3-((3-amino-4-methylaminobenzoyl)pyridin-2-ylamino)propionic acid ethyl ester; Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate; N-[3-amino-4-(methylamino)benzoyl]-N-2-pyridinyl-β-alanine, ethyl ester
- 212322-56-0
- C18H22N4O3
- 342.3923
- InChI=1/C18H22N4O3/c1-3-25-17(23)9-11-22(16-6-4-5-10-21-16)18(24)13-7-8-15(20-2)14(19)12-13/h4-8,10,12,20H,3,9,11,19H2,1-2H3
- 1.262g/cm3
- 576.155°C at 760 mmHg
- 1.64
- 302.248°C
- 0mmHg at 25°C
-
-
-